1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmaceutical Continuous Manufacturing Market – By Product
1.3.2 Global Pharmaceutical Continuous Manufacturing Market – By Application
1.3.3 Global Pharmaceutical Continuous Manufacturing Market – By End User
1.3.4 Global Pharmaceutical Continuous Manufacturing Market – By Geography
2. Pharmaceutical Continuous Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pharmaceutical Continuous Manufacturing – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion
5. Global Pharmaceutical Continuous Manufacturing Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Shortage of Medicines
5.1.2 Advantages Offered by Continuous Manufacturing Process
5.2 Key Market Restraints
5.2.1 High Capital Investments
5.3 Key Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
5.5 Impact Analysis
6. Pharmaceutical Continuous Manufacturing Market – Global Analysis
6.1 Global Pharmaceutical Continuous Manufacturing Market Revenue Forecast And Analysis
6.2 Global Pharmaceutical Continuous Manufacturing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Pharmaceutical Continuous Manufacturing Market Analysis – By Product
7.1 Overview
7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
7.3 Integrated Systems
7.3.1 Overview
7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Semi-Continuous Systems
7.4.1 Overview
7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.3 Continuous Granulators
7.4.3.1 Overview
7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.4 Continuous Blenders
7.4.4.1 Overview
7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.5 Continuous Compressors
7.4.5.1 Overview
7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.6 Continuous Coaters
7.4.6.1 Overview
7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.7 Continuous Dryers
7.4.7.1 Overview
7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.8 Other Semi-Continuous Systems
7.4.8.1 Overview
7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Controls
7.5.1 Overview
7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Continuous Manufacturing Market– By Application
8.1 Overview
8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
8.3 End Product Manufacturing
8.3.1 Overview
8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.3 Solid Dosage Manufacturing
8.3.3.1 Overview
8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.4 Liquid Dosage Manufacturing
8.3.4.1 Overview
8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.4 API Manufacturing
8.4.1 Overview
8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9. Pharmaceutical Continuous Manufacturing Market – By End User
9.1 Overview
9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
9.3 Full-Scale Manufacturing Companies
9.3.1 Overview
9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.3 Pharmaceutical Companies
9.3.3.1 Overview
9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.4 Contract Manufacturing Organizations
9.3.4.1 Overview
9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4 R&D Departments
9.4.1 Overview
9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.3 Contract Research Organizations
9.4.3.1 Overview
9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.4 Research Institutes
9.4.4.1 Overview
9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
10. Pharmaceutical Continuous Manufacturing Market – Geographic Analysis
10.1.1 Overview
10.1.2 North America: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.3.1 North America: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.4 North America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.4.1 North America: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.5 North America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.5.1 North America: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.5.2 North America: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.6 North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)
10.1.7 US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.7.2.1 US: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.7.3 US: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.7.3.1 US: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.7.4 US: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.7.4.1 US: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.7.4.2 US: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.8 Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.8.2.1 Canada: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.8.3 Canada: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.8.3.1 Canada: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.8.4 Canada: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.8.4.1 Canada: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.8.4.2 Canada: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.9 Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.9.2.1 Mexico: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.9.3 Mexico: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.9.3.1 Mexico: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.9.4 Mexico: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.9.4.1 Mexico: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.9.4.2 Mexico: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2 Europe: Pharmaceutical Continuous Manufacturing Market
10.2.1 Overview
10.2.2 Europe: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.3.1 Europe: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.4 Europe: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.4.1 Europe: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.5 Europe: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.5.1 Europe: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.5.2 Europe: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.6 Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.2.7 Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.7.2.1 Germany: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.7.3 Germany: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.7.3.1 Germany: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.7.4 Germany: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.7.4.1 Germany: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.7.4.2 Germany: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.8 UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.8.2.1 UK: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.8.3 UK: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.8.3.1 UK: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.8.4 UK: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.8.4.1 UK: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.8.4.2 UK: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.9 France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.9.2.1 France: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.9.3 France: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.9.3.1 France: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.9.4 France: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.9.4.1 France: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.9.4.2 France: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.10 Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.10.2.1 Spain: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.10.3 Spain: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.10.3.1 Spain: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.10.4 Spain: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.10.4.1 Spain: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.10.4.2 Spain: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.2.11 Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.2.11.2.1 Italy: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.2.11.3 Italy: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.2.11.3.1 Italy: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.2.11.4 Italy: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.2.11.4.1 Italy: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.2.11.4.2 Italy: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market
10.3.1 Overview
10.3.2 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.2.1 Asia Pacific: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.3.1 Asia Pacific: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.4.1 Asia Pacific: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.4.2 Asia Pacific: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.3.6 China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.6.1 China: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.6.1.1 China: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.6.2 China: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.6.2.1 China: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.6.3 China: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.6.3.1 China: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.6.3.2 China: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.7 Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Japan: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.7.1.1 Japan: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.7.2 Japan: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.7.2.1 Japan: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.7.3 Japan: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.7.3.1 Japan: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.7.3.2 Japan: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.8 India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 India: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.8.2.1 India: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.8.3 India: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.8.3.1 India: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.8.4 India: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.8.4.1 India: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.8.4.2 India: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.9 South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Korea: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.9.2.1 South Korea: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.9.3 South Korea: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.9.3.1 South Korea: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.9.4 South Korea: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.9.4.1 South Korea: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.9.4.2 South Korea: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.3.10 Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 Australia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.3.10.2.1 Australia: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.3.10.3 Australia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.3.10.3.1 Australia: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.3.10.4 Australia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.3.10.4.1 Australia: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.3.10.4.2 Australia: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.3 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.3.1 Middle East & Africa: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.4.1 Middle East & Africa: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.5 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.5.1 Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.5.2 Middle East & Africa: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4.6 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country – 2019 & 2027, (%)
10.4.7 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.7.2.1 Saudi Arabia: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.7.3 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.7.3.1 Saudi Arabia: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.7.4 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.7.4.1 Saudi Arabia: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.7.4.2 Saudi Arabia: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4.8 UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.8.2.1 UAE: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.8.3 UAE: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.8.3.1 UAE: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.8.4 UAE: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.8.4.1 UAE: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.8.4.2 UAE: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.4.9 South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (US$ Million)
10.4.9.1 South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.4.9.2.1 South Africa: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.4.9.3 South Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.4.9.3.1 South Africa: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.4.9.4 South Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.4.9.4.1 South Africa: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.4.9.4.2 South Africa: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.5 South and Central America: Pharmaceutical Continuous Manufacturing Market
10.5.1 Overview
10.5.2 South and Central America: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.5.3.1 South and Central America: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.5.4 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.5.4.1 South and Central America: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.5.5 South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.5.5.1 South and Central America: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.5.5.2 South and Central America: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.5.6 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.5.7 Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.5.7.2.1 Brazil: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.5.7.3 Brazil: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.5.7.3.1 Brazil: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.5.7.4 Brazil: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.5.7.4.1 Brazil: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.5.7.4.2 Brazil: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.5.8 Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.5.8.2.1 Argentina: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.5.8.3 Argentina: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.5.8.3.1 Argentina: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.5.8.4 Argentina: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.5.8.4.1 Argentina: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.5.8.4.2 Argentina: R&D Departments Market, by Type, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of World: Impact Assessment of COVID-19 Pandemic
12. Pharmaceutical Continuous Manufacturing Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 GEA Group
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Coperion GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Gericke AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Glatt GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hosokawa Micron Group
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Munson Machinery Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Powrex Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 THERMO FISHER SCIENTIFIC INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ACG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cadmach Machinery Co. Pvt. Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Fette Compacting
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Freund-Vector Corporation
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 KORSCH AG
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 LEISTRITZ AG
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 ALEXANDERWERK AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hovione
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms